Shopping Cart
Remove All
Your shopping cart is currently empty
Tamgiblimab (IBI939) is a fully humanized monoclonal antibody targeting TIGIT (T-cell immunoreceptor with immunoglobulin and ITIM domains), applicable for cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $123 | - | In Stock | |
| 5 mg | $297 | - | In Stock | |
| 10 mg | $455 | - | In Stock | |
| 25 mg | $733 | - | In Stock | |
| 50 mg | $987 | - | In Stock |
| Description | Tamgiblimab (IBI939) is a fully humanized monoclonal antibody targeting TIGIT (T-cell immunoreceptor with immunoglobulin and ITIM domains), applicable for cancer research. |
| Synonyms | IBI-939, IBI939, IBI 939 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | TIGIT |
| Cas No. | 2411914-36-6 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG4SP-FLAA-noK |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.